Home » Posts tagged with » Pharmaceutical Benefits Scheme
WA AIDS Council disappointed PrEP not yet added to PBS

WA AIDS Council disappointed PrEP not yet added to PBS

The Western Australian AIDS Council say they are disappointed that the Pharmaceutical Benefits Advisory Committee’s (PBAC) has decided to defer the decision on whether to list Pre-exposure Prophylaxis (PrEP) on the Pharmaceutical Benefits Scheme (PBS). Negotiation between the PBAC and the manufacturers of the drug Tenofovir which is used in PrEP treatment appear to have […]

Tags: , , , , , , , , , , ,

UK ready to roll out PrEP trial

UK ready to roll out PrEP trial

The United Kingdom will launch a PrEP trial that will allow 10,000 people to access game-changing HIV preventative medication. Britain’s National Health Service had ruled out offering PrEP treatment to help stop the transmission of HIV, but subsequently lost a court battle over the decision. The new £10 million trial with see 10,000 people being […]

Tags: , , , , , , , , , ,

Read More

HIV prevention drug will not be added to the PBS

HIV prevention drug will not be added to the PBS

Truvada, the drug that makes a huge difference in preventing the spread of HIV, will not be added to Australia’s Pharmaceutical Benefits Scheme (PBS). The game changing medication failed to gain a recommendation that it should be added the tax payer funded scheme.  HIV advocacy groups have described the decision as extremely disappointing. Commonly known […]

Tags: , , , , , , , , , , , ,

Read More

The Greens launch a raft of LGBTIQ related policies

The Greens launch a raft of LGBTIQ related policies

The Australian Greens announced a raft of policies relating to the LGBTIQ community. The annoucement was made yesterday during International Day Against Homophobia, Biphobia, Intersexism and Transphobia. The party said it would commit to $32 million full roll out of the Safe Schools program, removal of religious exemptions to federal anti-discrimination law and work to […]

Tags: , , , , , , , , , , , , ,

Read More